Population
Newly generated mice with a megakaryocyte-specific ADAM10 deficiency, Adam17 mice lacking functional ADAM17…
Design
Preclinical
Authors
Loading...
Challenges single-enzyme GPVI targeting for antithrombosis; leaves open the therapeutic role of additional platelet sheddases.
GPVI ectodomain shedding is mediated by multiple differentially regulated platelet-expressed proteinases, including ADAM10, ADAM17, and at least one other unidentified enzyme, which has implications for antithrombotic therapy targeting GPVI.
Bender et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: